Citadel Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-266,575
Closed -$1.63M 7711
2021
Q3
$1.63M Buy
+266,575
New +$1.63M ﹤0.01% 3236
2021
Q2
Sell
-16,616
Closed -$149K 7454
2021
Q1
$149K Sell
16,616
-178,078
-91% -$1.6M ﹤0.01% 5607
2020
Q4
$2.25M Sell
194,694
-43,066
-18% -$497K ﹤0.01% 2455
2020
Q3
$2.48M Sell
237,760
-167,358
-41% -$1.74M ﹤0.01% 2075
2020
Q2
$5.33M Buy
405,118
+163,874
+68% +$2.16M ﹤0.01% 1483
2020
Q1
$1.9M Sell
241,244
-27,085
-10% -$213K ﹤0.01% 2265
2019
Q4
$5.55M Sell
268,329
-33,811
-11% -$700K ﹤0.01% 1567
2019
Q3
$4.14M Buy
302,140
+169,582
+128% +$2.32M ﹤0.01% 1801
2019
Q2
$1.63M Sell
132,558
-178,352
-57% -$2.19M ﹤0.01% 2582
2019
Q1
$3.88M Buy
310,910
+27,405
+10% +$342K ﹤0.01% 1752
2018
Q4
$3.21M Buy
283,505
+186,086
+191% +$2.11M ﹤0.01% 1818
2018
Q3
$1.82M Buy
+97,419
New +$1.82M ﹤0.01% 2285
2018
Q2
Sell
-157,062
Closed -$3.52M 4726
2018
Q1
$3.52M Buy
+157,062
New +$3.52M ﹤0.01% 1528
2017
Q4
Sell
-58,082
Closed -$1.4M 4425
2017
Q3
$1.4M Buy
+58,082
New +$1.4M ﹤0.01% 2054
2017
Q2
Hold
0
4353
2017
Q1
Sell
-36,723
Closed -$698K 4337
2016
Q4
$698K Buy
+36,723
New +$698K ﹤0.01% 2233
2016
Q3
Sell
-60,522
Closed -$906K 4256
2016
Q2
$906K Buy
+60,522
New +$906K ﹤0.01% 1888
2016
Q1
Sell
-5,116
Closed -$99K 4172
2015
Q4
$99K Buy
+5,116
New +$99K ﹤0.01% 3258
2015
Q3
Sell
-23,502
Closed -$514K 4404
2015
Q2
$514K Buy
+23,502
New +$514K ﹤0.01% 2534